Skip to main contentSkip to navigation
Sirius Investors
Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc.

BUGVF
OTCHealthcare

Primo Nutraceuticals Inc. (BUGVF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Primo Nutraceuticals Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2019
P/E Ratio
-1.75
Burn Risk
P/B Ratio
-12.41
Equity Deficit
Earnings Yield
-57.38%
Yield Gap

Profitability Health

2019
Return on Equity
712.19%
Strong
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data

Growth Indicators

2019
Revenue Growth
-
No data
Net Income Growth
-
No data
EPS Growth
-
No data

Efficiency & Liquidity

2019
Current Ratio
0.02
Weak
WeakModerateStrong
Quick Ratio
0.02
Weak
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2019
Free Cash Flow Yield
-20.10%
Weak
WeakModerateStrong
EV / Free Cash Flow
-5.41x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.50x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
3.251
Strong
WeakModerateStrong
Return on Invested Capital
-22.56%
Weak
WeakModerateStrong
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for BUGVF.

View Financial Statements